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Abstract
Objective: Magnetic resonance spectroscopy (MRS) provides an exceptional opportunity for the study of in vivo
metabolism. MRS is widely used to measure phosphorus metabolites in trained muscle, although there are no published
data regarding its reproducibility in this specialized cohort. Thus, the aim of this study was to assess the reproducibility of
31P-MRS in trained skeletal muscle.
Methods: We recruited fifteen trained men (VO2peak=4.760.8 L min
21/5868m Lk g
21 min
21) and performed duplicate
MR experiments during plantar flexion exercise, three weeks apart.
Results: Measures of resting phosphorus metabolites were reproducible, with 1.7 mM the smallest detectable difference in
phosphocreatine (PCr). Measures of metabolites during exercise were less reliable: exercising PCr had a coefficient of
variation (CV) of 27% during exercise, compared with 8% at rest. Estimates of mitochondrial function were variable, but
experimentally useful. The CV of PCr1/2t was 40%, yet much of this variance was inter-subject such that differences of ,20%
were detectable with n=15, given a significance threshold of p,0.05.
Conclusions: 31-phosphorus MRS provides reproducible and experimentally useful measures of phosphorus metabolites
and mitochondrial function in trained human skeletal muscle.
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Introduction
Magnetic resonance spectroscopy (MRS) is unmatched in its
ability to measure tissue biochemistry in intact humans without the
need for invasive procedures or the administration of potentially
harmful radioactive isotopic tracers. In particular, it has been used
extensively to monitor 31-phosphorus (
31P) metabolites in both
cardiac [1] and skeletal muscle [2]. Due to the large volume and
easy accessibility of the skeletal muscles of the human leg,
31P-MR
spectra can be acquired from a localized volume of leg muscle with
excellent temporal (.1/s) resolution. Thus
31P-MRS can be used
to measure steady-state concentrations of high-energy phosphorus
metabolites in resting skeletal muscle and phosphorus metabolite
kinetics during exercise and recovery in a single experiment. It has
long been known that the kinetic constants during work transitions
provide an insight into the energy metabolism of the exercising
(and recovering) muscle (cf [3]). Therefore resting phosphorus
metabolites, and their kinetics during transitions from exercise to
rest, have been widely used to assess muscle energetic status and
energy metabolism, both in healthy subjects [4,5,6,7,8] and in
patients with a wide range of diseases [9,10,11,12,13]. Indeed, in
many cases MRS may well provide the only accurate in vivo
measure of metabolites with rapid turnover in humans and
experimental animals.
There have been two recent reports on the reproducibility of
31P-MRS measurements in healthy untrained human skeletal
muscle [14,15]. These recent papers added to an existing body of
work using a range of experimental approaches that are
summarized in Table 1. Results from these diverse approaches
have been quite consistent in showing that
31P-MRS is generally
very reproducible, although one of the more comprehensive
studies [14] seemed to suggest that estimates of mitochondrial
function (made using kinetic data) are less so, at least compared
with measurements of resting phosphocreatine concentration. In
addition, the reproducibility studies that have been conducted
using repeated testing in a single subject [16,17,18], although
helpful in uncovering measurement or intra-individual variability,
are unable to detect either systematic bias or population-
dependent (inter-individual) variability.
Investigators in other fields have found that there are differences
(both improvements and decrements) in the reproducibility of
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opposed to untrained controls [19,20]. As with sedentary or
moderately active subjects,
31P-MRS is widely used to measure
phosphorus metabolites and kinetics in the muscles of trained
subjects, yet Table 1 shows that there are no published data
reporting directly on the reproducibility of the method in this
specialized cohort. However, what data there are suggest that both
the inter- and within-subject variability of
31P-MRS indices of
mitochondrial function may differ markedly in athletes; for
example, recently published data suggest that the coefficients of
variation of several estimates of mitochondrial oxidative rate differ
more than sevenfold between sedentary and endurance-trained
subjects [21]. Thus, the aim of this study was to assess the
reproducibility of MRS measures of 31-phosphorus metabolism in
trained human skeletal muscle. We hypothesized that, despite
differences in oxidative capacity between a trained and an
untrained cohort,
31P-MRS would continue to provide reliable,
repeatable and useful measures of muscle biochemistry in vivo.
Methods
Ethics Statement
The Central Oxfordshire Research Ethics Committee approved
this study and fully-informed written consent was obtained from all
subjects. All protocols were conducted in accordance with the
Declaration of Helsinki.
These data were acquired as part of a larger study. We recruited
fifteen trained men from the Oxford rowing crews. We chose
rowers for our study based on their participation in an aerobic
sport that requires significant recruitment of the plantar flexion
muscles of the lower leg [22]. Standard MR contraindications
were excluded by history and physical examination. Peak aerobic
capacity ( V VO2peak) was measured as described in detail elsewhere
[23,24]. Ventilatory threshold was calculated according to the V-
slope method [25], using software supplied for use with the
Metamax system (Metasoft 3, Cortex, Biophysik, Germany).
Subsequent MR experiments, the details of which have been
published elsewhere [23,24,26], were performed twice, three
weeks apart. Subjects were instructed to maintain normal training
patterns for the two weeks prior to each measurement. Each
subject performed plantar flexion exercise in a Siemens Trio 3T
clinical MR system (Siemens, Erlangen, Germany), with a 6 cm
dual-tuned
31P and
1H surface coil placed under the widest part of
the right gastrocnemius. A special wooden housing was con-
structed to ensure that coil positioning was consistent and
repeatable. Positioning was further refined through the use of
scout images. Prior to the acquisition of
31P MR time-series data,
three baseline scans were acquired to allow calculation of
correction factors for partial saturation due to the short repetition
time (TR) in the main acquisition, and for nuclear Overhauser
enhancement (NOE). The acquisition parameters for the
31P time-
series were TR 500 ms, TE 0.35 ms, bandwidth 2000 Hz, 10
averages, 512 data points, excitation flip angle 25u and 10
rectangular NOE pulses, with pulse duration 10 ms, inter-pulse
delay 10 ms and excitation flip angle 180u. The MR exercise
protocol was: 5 min rest, 5 min very light exercise (warm-up),
7 min recovery, 5 min at 5 W, 7 min recovery, 5 min at 6 W,
5 min recovery. Exercising values are the means of the last
minutes of bouts 2 and 3. Figure 1 shows a typical set of spectra,
acquired at 5-second intervals during the recovery phase.
Spectra were processed using jMRUI version 2.2 [27] and
quantified using a non-linear least squares algorithm [28]. The
resting ATP concentration was taken as 8.2 mM [2]. The
chemical shift of the inorganic phosphate (Pi) peak, relative to
phosphocreatine (PCr), was used to determine intracellular pH.
Intracellular [ADP] was calculated making the standard assump-
tion that the creatine kinase reaction was at equilibrium, and
correcting for pH [29]. The halftime of PCr recovery after
moderate exercise (PCrt1/2) was determined by fitting a monexpo-
nential equation to the PCr recovery data. Figure 2 shows a typical
fit to experimental data. The maximum rate of mitochondrial
ATP synthesis (QMAX) was extrapolated from the end-exercise
[ADP] and corresponding rate of PCr resynthesis as in [30].
Technical issues caused a loss of data for calculation of QMAX in
a single subject. Thus n=14 for this and associated measurements.
Statistical analyses were conducted using PASW 18.0 (SPSS
Inc., Chicago, USA). Reproducibility was assessed using tech-
niques drawn from [31] and [32]. Heteroscedasticity was treated
as significant if the correlation between the means of the repeated
measures and the absolute difference between them was positive
and significant at p,0.05. In these cases, data were log
transformed. A paired t-test was used to assess test-retest bias.
The standard deviation of the differences was taken as an index of
test-retest variability. In addition to these traditional methods,
95% confidence intervals of the differences between means were
calculated. In the case of heteroscedastic data, 95% confidence
intervals were calculated for the log-transformed data. When
Table 1. Summary of published data regarding the reproducibility of
31P-magnetic resonance spectroscopy in skeletal muscle (in
chronological order).
Experimental
design Timing Cohort
Exercise modality/
muscle group Reference
Multiple test-retest 20 minutes between tests 1 healthy subject Isometric/thumb Miller et al. (1987) [17]
Single test-retest 1 month between tests 1 healthy female subject Isometric/calf Miller et al. (1995) [16]
Multiple test-retest ‘two different days’ 4 moderately active subjects Dynamic/calf Walter et al. (1997) [41]
Single test-retest 1 month between tests 7 healthy untrained females Isometric/calf Larson-Meyer et al. (2000) [37]
Single test-retest 1 week between tests 18 sedentary males (‘who complained of fatigue’) Dynamic/finger Bendahan et al. (2002) [42]
Multiple test-retest 24 hours 14 children Dynamic/thigh Barker et al. (2006) [43]
Multiple test-retest N/a 1 healthy subject Dynamic/thigh Van den Broek et al. (2007) [18]
Multiple test-retest 1 month/1 year between tests 11 untrained males+1 untrained female Dynamic/thigh Layec et al. (2009) [14]
Multiple test-retest ‘1–30 days’ between tests 12 healthy untrained males Isometric/thigh McCully et al. (2009) [15]
doi:10.1371/journal.pone.0037237.t001
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such. In the main text, data are reported as means (SD).
Results
The subjects (n=15) were aged 22 (1) years, weighed 82 (9) kg
(Table 2). They had a peak aerobic capacity of 4.7 (0.8) L min
21
(58 (8) mL min
21 kg
21) and a ventilatory threshold of 75 (12) % of
peak power, confirming their trained status.
Table 3 summarises the results of our analysis, giving the means
and standard deviations of the first and second measures in each
case, accompanied by the grand coefficient of variation (CV)
where applicable. For example, muscle phosphocreatine content
was measured as 30 (3) mM on the first visit and 29 (2) mM on the
second; the CV for this measurement was 8%. Figure 3 shows the
group means (and standard errors) for phosphocreatine concen-
tration in recovery from dynamic exercise.
Table 3 also shows the results of our tests of heteroscedasticity,
as recommended by Nevill and Atkinson [32]. In two cases
(exercising [Pi] and Qmax) there was convincing evidence of
heteroscedasticity (i.e. a significant positive correlation between the
absolute magnitude of the difference between two observations
and their mean). These data were log-transformed and tested for
heteroscedasticity again. In both cases the heteroscedasticity was
resolved.
We looked for test-retest bias (for example, instrument drift or
a learning effect) using a paired t-test comparing the first and
second measurements. Table 3 shows that there was no significant
test-retest bias in any of the measures taken. The standard
deviation of the differences between the first and second measures
(‘Error (SD of diff.)’ in Table 3) is an index measurement
Figure 1. Stacked plot showing 31-phosphorus magnetic resonance spectra acquired at 5-second intervals from the calf muscle of
a single trained subject in recovery from dynamic exercise.
doi:10.1371/journal.pone.0037237.g001
Figure 2. Typical experimental data (phosphocreatine concen-
tration, normalised to resting values, in recovery from dynamic
exercise) and a monoexponential function (solid line), fitted as
described in Methods.
doi:10.1371/journal.pone.0037237.g002
Table 2. Subjects’ characteristics (n=15).
Age (y) 22 (1)
Mass (kg) 82 (9)
Absolute VO2peak (L min
21) 4.7 (0.8)
Relative VO2peak (mL min
21 kg
21) 58 (8)
Ventilatory threshold (%) 75 (12)
doi:10.1371/journal.pone.0037237.t002
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extended this approach by calculating the 95% confidence
intervals for the differences between the first and second measures.
These confidence intervals give the minimum limits for the
detection of changes at a significance threshold of p,0.05. For
example, in our trained cohort of fifteen, an increase in resting
muscle [PCr] of .0.5 mM or a decrease of .2.9 mM would have
been significant at the p,0.05 level. In the case of log-transformed
data these confidence limits were antilogged to provide a 95%
confidence ‘ratio’. For example, in our cohort an increase in
exercising [Pi] of .24% or a decrease of .6% would have been
significant at p,0.05.
In all cases the 95% confidence intervals were not symmetrical
due to nonsignificant bias. If one assumes that bias was not present
(as the data suggest) then the confidence intervals can be corrected.
Thus a change in resting muscle [PCr] of 61.7 mM ((0.5+2.9)/2)
could be reasonably assumed to be detectable at p,0.05 using our
methods and with n=15. Likewise, the minimum detectable
change in exercising [Pi] would be 615%.
Discussion
We studied the reproducibility of
31P-MRS indices of muscle
metabolism in a trained cohort, for the first time (to our
knowledge). We found that measures of resting metabolites were
the most repeatable, with CVs of 8% (PCr) and 17% (Pi).
Exercising metabolites were more variable (27% (PCr) and 47%
(Pi)). Finally, measures of mitochondrial function such as PCr1/2t,
while highly variable (CV=40%) were still experimentally useful
providing a relative detection threshold of ,20% (n=15, p,0.05).
Training (and recovery) stimulates adaptive physiological
changes that vary widely in their timing. Thus it seems reasonable
to suggest that the coefficients of variation of a range of
physiological parameters measured in athletes may be different
to those in sedentary subjects. This hypothesis has led researchers
in other areas to specifically study the effect of exercise training on
the reproducibility of various experimental methods [19,20].
Bingisser et al.
19 found that there were significant differences in
reproducibility between measures taken in trained vs. untrained
subjects, with the trained subjects being more homogenous and
thus more reproducible in the measures that were studied.
Likewise, Heitkamp and colleagues
20 studied the reproducibility
of the lactate threshold in trained vs. untrained women. Once
again, measurements in the trained women were somewhat more
reliable.
Among the many well-known adaptive changes that follow from
high levels of physical activity, exercise training stimulates changes
in muscle gene transcription [33]. This may explain why muscle
oxidative enzyme activity can vary widely in trained or highly-
active humans compared with those who are sedentary [34], and
why the coefficients of variation of
31P-MRS estimates of
mitochondrial function can differ markedly in athletes compared
to controls [21]. Furthermore, within trained subjects the
peripheral training effect can vary dramatically even at the same
relative VO2 [35]. Consistent with this, the coefficients of variation
(CV) we observed in our trained cohort were larger than those
reported in untrained subjects [14]. For example, the CV of
resting [PCr] in our trained cohort was 8%, compared with 2.2%
reported by Layec et al. [14] and ,5% by Roussel and co-workers
[36]. Yet resting muscle pH, which one would not expect to vary
with training status, had a very similar CV in our trained cohort
vs. earlier studies in untrained subjects: the CV of resting muscle
pH was 0.2% in our hands and was reported as being 0.28% by
Layec et al. [14], 0.4% by Roussel et al. [36] and 0.1% by Larson-
Meyer and colleagues [37]. Given that the calculation of muscle
pH from
31P-MRS data utilises two independent peaks in a single
spectrum, this comparability between the two studies reinforces
that our data were of a similar quality to those earlier studies.
Yet despite the slightly greater variation,
31P-MRS in athletes
had excellent reproducibility when measuring intramuscular
phosphates. In the absence of significant bias, the smallest
detectable difference for a given n can be estimated from the
mean of the absolute values of the confidence intervals (as outlined
in Results). Using this approach, we estimate that changes in [PCr]
of ,2.1 mM (7%) could be detected in just 10 trained subjects.
Consistent with earlier studies, measures of mitochondrial
function were more variable. Coefficients of variation in our
trained subjects were .30% for both PCr1/2t and QMAX. This is
compared to coefficients of variation of ,20% for PCr1/2t [14,15]
13–30% for Qmax [14] in other studies. However, the measure-
ment of PCr1/2t in athletes is unfairly described by these statistics.
Although there was a high degree of inter-individual variation,
analysis of the differences (measurement 2– measurement 1)
suggested that changes of ,20% could be detected in 15 trained
subjects, an eminently feasible number for practical research,
particularly given that endurance trained individuals have a QMAX
that is close to double that of untrained individuals [38] and
exercise training can induce increases in mitochondrial function of
the order of up to 50% in the untrained elderly [39]. The
reliability of measurements of metabolite concentration during
exercise lay between those same measurements at rest and the
indices of mitochondrial function (Table 3). The increased
variation relative to resting measurements could be attributed to
several sources: First, despite heavy strapping and careful
experimental design, noise may been generated due to motion/
contraction of the target muscles. In addition, variations in aerobic
fitness/mitochondrial function and, possibly, ATP-economy of
contraction were likely to have contributed to increased variance
[40].
Figure 3. Phosphocreatine (PCr) recovery (normalised to
resting values) in trained human calf muscle after dynamic
exercise during two separate but identical tests. Values shown
are means6SEM.
doi:10.1371/journal.pone.0037237.g003
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training schedules led to increased variability. However, our aim
was to assess reproducibility in this cohort under ‘normal’
conditions (i.e. without strict training control). Nevertheless, the
lack of any evidence for increased variability suggests that tight
controls may be unnecessary during magnetic resonance studies of
athletes.
There were three potential sources of variability in our data:
variability in the instrument, physiological variation and proces-
sing variability (for example, slight differences in the selection of
data used for curve fitting). Earlier studies have addressed these
issues by i. Duplicate acquisitions from the same subject under
identical conditions (i.e. in immediate succession, cf. [17]), ii.
Repeated measurements on the same individual at different times
(as in the present study) and iii. Duplicate processing of the same
data by the same experimenter on different occasions (as in [14]).
The existing work suggests that instrument variability and
processing variability contribute rather little to the overall
variability. Thus it seems reasonable to suggest that the bulk of
the variability we observed was physiological in nature. However,
these three sources of variability are difficult to separate entirely
(for example, a given instrument may operate with greater
variability across several days or months, but no living biological
matrix is unchanging across these timescales). For the present
study we chose not to separate these sources of variation as, in
practice, they are all present; our aim was to produce benchmark
data regarding the reliability of the method as a whole. One must
consider that our study used athletes whose training was not being
directly controlled by the experimenters. As such, variations in
training load or the timing of experimental acquisition relative to
training sessions may have introduced greater variability than in
a cohort where training was rigorously controlled.
To conclude, we studied the reproducibility of
31P-MRS
measures of muscle phosphorus metabolism in a cohort of trained
men. The coefficients of variation in this cohort appear to be
slightly larger than in earlier, similar studies that used untrained
subjects. However, these larger coefficients of variation appeared
to be the result of larger inter-individual variation, while test-retest
reliability remained good. Thus we found the method to be
reproducible and reliable enough for studies to be conducted using
relatively small numbers of trained participants, especially where
paired statistical comparisons will be used.
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